Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic study of ACE, AGT, CYP11B1, CYP11B2 and eNOS gene variants in hypertensive patients from Faisalabad, Pakistan.

JPMA. The Journal of the Pakistan Medical Association - 1 Apr 2020

Hussain Misbah, Bilal Ahmed, Awan Fazli Rabbi

Abstract excerpt

OBJECTIVE: To investigate the association of genetic variants of renin angiotensin aldosterone system, endothelial nitric oxide synthase and 11-beta-hydroxylase genes, and the drug efficacy of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. METHODS: This two time-point study was conducted from April to November 2016 at Allied Hospital, Faisalabad and National Institute for Biotechnology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Angiotensin Receptor Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Angiotensinogen

Share to Nitric Oxide Synthase Type III

Share to Pakistan

Share to Peptidyl-Dipeptidase A

Share to Pharmacogenomic Testing

Share to Pharmacogenomic Variants

Source

Identifiers

PMID: 32296206
DOI: 10.5455/JPMA.6666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic study of ACE, AGT, CYP11B1, CYP11B2 and eNOS gene variants in hypertensive patients from Faisalabad, Pakistan.PMID 32296206Read ↗

Genetic polymorphisms influencing antihypertensive drug responsesSemantic proximity Read ↗

Impact of lifestyle modification practices and pharmacogenetics of ACE I/D gene polymorphism in grade 1 hypertensive patientSemantic proximity Read ↗

Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseasesSemantic proximity Read ↗

Genetic and phenotypic frequency distribution of ACE, ADRB1, AGTR1, CYP2C9*3, CYP2D6*10, CYP3A5*3, NPPA and factors associated with hypertension in Chinese Han hypertensive patients.Semantic proximity Read ↗

Hypertension subtypes and angiotensin converting enzyme (ACE) gene polymorphism in Indian population.Semantic proximity Read ↗

Hypertension pharmacogenetics and limitations in Africa - a focus on the ACE, AGTR1 and CYP2C9 genes.Semantic proximity Read ↗

Association between plasma angiotensinogen level and response to valsartan among sample of Iraqi hypertensive patients.Semantic proximity Read ↗

In silico Approach for Exploring the Role of AT1R Polymorphism on its Function, Structure and Drug InteractionsSemantic proximity Read ↗

AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis.Semantic proximity Read ↗

Exploring AT2R and its Polymorphism in Different Diseases: An Approach to Develop AT2R as a Drug Target beyond Hypertension.Semantic proximity Read ↗

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in IraqSemantic proximity Read ↗

Genetic determinants of hypertension: A meta-analysis of AGTR1 and CYP11B2 gene polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.